NCT06432504 Variation in the Impact of Coffee on the Metabolic Rate
| NCT ID | NCT06432504 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-03-06 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-03-06 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to explore variation in the impact of coffee on metabolic rate. The investigators plan to recruit healthy participants, half male and half female.
Eligibility Criteria
Inclusion Criteria: Healthy adults 18-40 years old Exclusion Criteria: Those who have undergone surgery in the past 6 months. People are requiring long-term medication. People have metabolic diseases, like diabetes, hypoglycemia, gout, osteoporosis, etc. People have digestive diseases, like gastric ulcer, pancreatitis, intestinal obstruction, etc. Those who have recently lost weight for various medical reasons ( like cancer, etc.). People are suffering from infectious diseases ( like HIV, etc.). People have blood phobia, pathological hypo or hyper tension. People with impaired glucose tolerance. Those who are afflicted with claustrophobia.
Contact & Investigator
John R Speakman, PhD
STUDY CHAIR
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Frequently Asked Questions
Who can join the NCT06432504 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06432504 currently recruiting?
Yes, NCT06432504 is actively recruiting participants. Contact the research team at j.speakman@abdn.ac.uk for enrollment information.
Where is the NCT06432504 trial being conducted?
This trial is being conducted at Shenzhen, China.
Who is sponsoring the NCT06432504 clinical trial?
NCT06432504 is sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The principal investigator is John R Speakman, PhD at Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The trial plans to enroll 100 participants.